Report Overview
The global Crude Heparin market size is projected to grow from US$ 3561 million in 2024 to US$ 4866 million in 2030; it is expected to grow at a CAGR of 5.3% from 2024 to 2030.
Analytic Insights Hub (AIH) ' newest research report, the “Crude Heparin Industry Forecast” looks at past sales and reviews total world Crude Heparin sales in 2023, providing a comprehensive analysis by region and market sector of projected Crude Heparin sales for 2024 through 2030. With Crude Heparin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crude Heparin industry.
This Insight Report provides a comprehensive analysis of the global Crude Heparin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crude Heparin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Crude Heparin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crude Heparin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crude Heparin.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
This report presents a comprehensive overview, market shares, and growth opportunities of Crude Heparin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Segmentation by Application:
UFH
LMWH
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Crude Heparin market?
What factors are driving Crude Heparin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Crude Heparin market opportunities vary by end market size?
How does Crude Heparin break out by Type, by Application?
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Crude Heparin Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Crude Heparin Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Crude Heparin Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Crude Heparin Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Crude Heparin Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Crude Heparin Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Crude Heparin Market-Segmentation by Geography
10 North America
10.1 North America Crude Heparin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Crude Heparin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Crude Heparin Production Analysis from 2017-2023
10.4 North America Crude Heparin Consumption Analysis from 2017-2023
10.5 North America Crude Heparin Import and Export from 2017-2023
10.6 North America Crude Heparin Value, Production and Market Share by Type (2017-2023)
10.7 North America Crude Heparin Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Crude Heparin by Country (United States, Canada)
10.8.1 North America Crude Heparin Sales by Country (2017-2023)
10.8.2 North America Crude Heparin Consumption Value by Country (2017-2023)
10.9 North America Crude Heparin Market PEST Analysis
11 Europe
11.1 Europe Crude Heparin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Crude Heparin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Crude Heparin Production Analysis from 2017-2023
11.4 Europe Crude Heparin Consumption Analysis from 2017-2023
11.5 Europe Crude Heparin Import and Export from 2017-2023
11.6 Europe Crude Heparin Value, Production and Market Share by Type (2017-2023)
11.7 Europe Crude Heparin Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Crude Heparin by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Crude Heparin Sales by Country (2017-2023)
11.8.2 Europe Crude Heparin Consumption Value by Country (2017-2023)
11.9 Europe Crude Heparin Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Crude Heparin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Crude Heparin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Crude Heparin Production Analysis from 2017-2023
12.4 Asia-Pacific Crude Heparin Consumption Analysis from 2017-2023
12.5 Asia-Pacific Crude Heparin Import and Export from 2017-2023
12.6 Asia-Pacific Crude Heparin Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Crude Heparin Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Crude Heparin by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Crude Heparin Sales by Country (2017-2023)
12.8.2 Asia-Pacific Crude Heparin Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Crude Heparin Market PEST Analysis
13 Latin America
13.1 Latin America Crude Heparin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Crude Heparin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Crude Heparin Production Analysis from 2017-2023
13.4 Latin America Crude Heparin Consumption Analysis from 2017-2023
13.5 Latin America Crude Heparin Import and Export from 2017-2023
13.6 Latin America Crude Heparin Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Crude Heparin Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Crude Heparin by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Crude Heparin Sales by Country (2017-2023)
13.8.2 Latin America Crude Heparin Consumption Value by Country (2017-2023)
13.9 Latin America Crude Heparin Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Crude Heparin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Crude Heparin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Crude Heparin Production Analysis from 2017-2023
14.4 Middle East & Africa Crude Heparin Consumption Analysis from 2017-2023
14.5 Middle East & Africa Crude Heparin Import and Export from 2017-2023
14.6 Middle East & Africa Crude Heparin Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Crude Heparin Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Crude Heparin by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Crude Heparin Sales by Country (2017-2023)
14.8.2 Middle East & Africa Crude Heparin Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Crude Heparin Market PEST Analysis
15 Future Forecast of the Global Crude Heparin Market from 2023-2029
15.1 Future Forecast of the Global Crude Heparin Market from 2023-2029 Segment by Region
15.2 Global Crude Heparin Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Crude Heparin Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source